Related Experiment Video

Updated: Jun 13, 2026

Prehospital Thrombolysis: A Manual from Berlin
05:52

Prehospital Thrombolysis: A Manual from Berlin

Published on: November 26, 2013

[Thrombolysis in acute coronary syndrome]

Hiroyuki Kawata1

  • 1First Department of Internal Medicine, Nara Medical University.

Nihon Rinsho. Japanese Journal of Clinical Medicine
|April 15, 2010
PubMed

Insights

Combining ultrasound with thrombolysis may improve treatment for acute myocardial infarction (AMI). This approach enhances blood clot dissolution, potentially offering a safer and more effective alternative for acute arterial thrombotic diseases.

Area of Science:

  • Cardiovascular Medicine
  • Interventional Cardiology
  • Biomedical Engineering

Context:

  • Acute myocardial infarction (AMI) prognosis depends heavily on timely recanalization.
  • Pharmacological thrombolysis is widely available but achieves lower reperfusion rates and carries risks of hemorrhage compared to percutaneous coronary intervention.
  • Existing treatments for AMI have limitations requiring novel therapeutic strategies.

Purpose:

  • To evaluate the efficacy of combining transcutaneous ultrasound with pharmacological thrombolysis.
  • To address the limitations of conventional thrombolysis, including suboptimal reperfusion and hemorrhagic complications.
  • To investigate a potential adjunctive therapy for acute arterial thrombotic diseases.

Summary:

  • An experimental study utilized a rabbit femoral artery occlusion model with platelet and fibrin-rich thrombi, mimicking AMI.
  • Transcutaneous ultrasound was combined with pharmacological thrombolysis to assess its effectiveness in facilitating clot dissolution.
  • The experimental results indicate that ultrasound-assisted thrombolysis shows promise in improving recanalization.

Impact:

  • This research suggests a potential benefit of transcutaneous ultrasound as an adjunct to thrombolysis for acute arterial thrombotic diseases, including AMI.
  • The findings may lead to improved treatment strategies for AMI, enhancing reperfusion rates and potentially reducing complications.
  • This study opens avenues for further research into non-invasive methods to augment pharmacological therapies in cardiovascular emergencies.

More Related Videos

An In vitro System to Gauge the Thrombolytic Efficacy of Histotripsy and a Lytic Drug07:50

An In vitro System to Gauge the Thrombolytic Efficacy of Histotripsy and a Lytic Drug

Published on: June 4, 2021

Related Concept Videos

Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
Venous Thrombosis III: Interprofessional Care01:29

Venous Thrombosis III: Interprofessional Care

Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care01:29

Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care

Diagnosing Pulmonary EmbolismDiagnosing pulmonary embolism (PE) involves clinical assessment and advanced imaging tests. The preferred diagnostic tool is the spiral (helical) CT scan or CT angiography (CTA), which uses intravenous contrast media to visualize the pulmonary vasculature and identify emboli.A ventilation-perfusion (V/Q) scan is an alternative for patients unable to receive contrast media. This scan includes both perfusion and ventilation scanning. Perfusion scanning involves...
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations01:19

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations

The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...